查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511854

流式细胞技术市场规模、份额、趋势分析报告：按产品、技术、最终用途、地区和细分市场进行预测，2024-2030 年

Flow Cytometry Market Size, Share & Trends Analysis Report By Product (Instruments, Software), By Technology (Bead-based, Cell-based), By Application (Industrial, Clinical), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 166 Pages | 商品交期: 2-10个工作天内

价格

流式细胞技术市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计到2030年，全球流式细胞技术市场规模将达到70.1亿美元，预测期内复合年增长率为6.96%。该技术的技术进步引入了新的和改进的分析工具，例如用于照护现场(PoC) 测试的微流体流式细胞技术的开发。此外，癌症、免疫力缺乏和感染疾病病率的上升正在推动该行业的发展。此外，生物製药、生命科学和生物技术研究活动的研发投资不断增加，导致对流式细胞技术设备的高需求。最近的趋势集中在开发用于 PoC 测试的可携式微流体流式细胞技术仪设备。

微射流和流式细胞技术的结合为测量生物样品的多种特性提供了有用的工具。例如，多种微流体和小型化检测器的出现促进了基于微晶片的细胞计数器的开发，例如光流控细胞计数器、成像细胞计数器和电阻细胞计数器。开发具有成本效益、便携式且紧凑的微流体流式细胞技术设备将是有益的。这些在亚洲和非洲等新兴经济体价格实惠且可用，从而促进了 PoC 测试应用的快速成长。此外，萤光染料的改进以及桌上型细胞仪在学术研究环境中的效用不断提高预计将推动该产业的发展。

多色流式细胞技术的发展正在加速该技术在开发新药活动中的采用。例如，2020年1月，贝克曼库尔特生命科学公司在欧洲推出了13色临床流式细胞技术系统DxFLEX、CE-IVD。同样，细胞分析和同时评估多个参数的简便性使得此类设备广泛用于合约研究目的。 COVID-19 大流行也刺激了技术创新，该领域新产品的推出证明了这一点。例如，2021 年 7 月，Metropolis Healthcare Ltd. 推出了 CoviRisk-TBNK，这是一种简单的血液检测，用于检测住院 COVID-19 患者的风险状态。

此测试有助于分析入住 ICU 和机械通气的需求，减少对医疗资源的压力。该测试是基于流式细胞技术的淋巴细胞亚群测定，并被核准作为体外诊断药物。预计此类技术创新将在不久的将来推动产业成长。此外，流式细胞技术是列出和表征免疫细胞的重要工具，还可以帮助识别和检验潜在的遗传缺陷。该技术也用于观察和监测干细胞移植后患者的免疫反应，使器官移植成为产业成长的关键驱动力。据世界卫生组织称，全球每年进行约5万例干细胞移植，这一数字可望拓展未来前景并扩大该技术的应用范围。

另一方面，设备非常昂贵，开发中国家可能买不起技术先进的流式细胞技术设备。这些设备的成本可能高达 10 万美元，为中小型医院和临床实验室带来了巨大的预算限制。但一些製造商，例如SONY，正在推出具有可自动执行许多流程的软体的新设备。此类发展不仅将提高技术的可用性，还将有助于在不久的将来降低平均设备成本（低于 100,000 美元）。

流式细胞技术市场报告亮点

  • 由于技术进步、慢性病盛行率增加，设备产品领域在 2023 年占据最大份额。
  • 由于对早期诊断的高需求以及对基于细胞的检测的相关优势的认识不断增强，基于细胞的流式细胞技术技术将在 2023 年占据行业主导地位。
  • 从应用来看，由于流感、HIV 和 COVID-19 等感染疾病相关活动的增加，临床细分市场在 2023 年占据了最大的收益占有率。
  • 由于学术机构和研究中心的研发活动增加，学术最终用户细分市场将在 2023 年引领市场。
  • 由于科学先进的流式细胞技术解决方案的广泛采用、高医疗保健支出和发达的医疗基础设施，北美在 2023 年引领市场。
  • 预计 2022 年至 2030 年亚太地区复合年增长率最快。这是由于中国和印度等新兴国家製药和生物技术行业的广泛增长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 配套市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 产业挑战
  • 营商环境分析
    • PESTEL分析
    • 波特五力分析
  • COVID-19 影响分析

第 4 章流式细胞技术市场 - 細項分析（按产品），2018-2030

  • 流式细胞技术市场：产品变异分析
  • 副产品
    • 装置
    • 试剂/耗材
    • 软体
    • 配件
    • 服务

第 5 章流式细胞技术市场 - 按技术細項分析，2018-2030 年

  • 流式细胞技术市场：技术波动分析
  • 依技术

第六章流式细胞技术市场 - 細項分析（按应用），2018-2030

  • 流式细胞技术市场：应用变化分析
  • 按用途
    • 研究
    • 产业
    • 临床

第 7 章流式细胞技术市场 – 細項分析（依最终用途），2018-2030

  • 流式细胞技术市场：最终用途变化分析
  • 按最终用途

第 8 章流式细胞技术市场：区域估计和趋势分析、按产品、技术、应用和最终用途

  • 流式细胞技术市场：区域展望
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第9章 竞争格局

  • 公司简介
    • DANAHER CORPORATION
    • BECTON, DICKINSON AND COMPANY（BD）
    • SYSMEX CORPORATION
    • AGILENT TECHNOLOGIES, INC.
    • APOGEE FLOW SYSTEMS LTD.
    • BIO-RAD LABORATORIES, INC.
    • THERMO FISHER SCIENTIFIC, INC.
    • STRATEDIGM, INC.
  • 公司分类
  • 2023 年流式细胞技术市场占有率分析
  • 策略规划
    • 併购
    • 伙伴关係与协作
    • 新产品发布
    • 其他的

第10章结论

Product Code: GVR-1-68038-412-3

Flow Cytometry Market Growth & Trends:

The global flow cytometry market size is expected to reach USD 7.01 billion by 2030, registering a CAGR of 6.96% over the forecast period, according to a new report by Grand View Research, Inc. Technological advancements in the technique are introducing new and improved analytical tools, which include the development of microfluidic flow cytometry for Point-of-Care (PoC) testing. Furthermore, the rising prevalence of cancer, immunodeficiency disorders, and infectious diseases is driving the industry. In addition, increasing R&D investments in biopharmaceutical, life science, and biotechnology research activities have led to high demand for flow cytometry instruments. In recent years, a key focus has been on the development of portable microfluidic flow cytometry devices for PoC testing.

Microfluidics and flow cytometry together make a useful tool to measure multiple characteristics of biological samples. For instance, the easy availability of several microfluidics and miniaturized detectors have enabled the creation of microchip-based cytometers, such as optofluidic cytometer, imaging cytometer, and impedance cytometer. The development of microfluidic flow cytometry devices, which are cost-effective, portable, and compact, is beneficial. They are affordable in developing economies, such as Asia & Africa, and are enabling rapid growth in PoC testing applications. Furthermore, improvements in fluorescent dyes and the increasing utility of benchtop cytometers for academic research settings are expected to drive the industry.

Developments in multicolor flow cytometry are accelerating the adoption of the technique in novel drug development activities. For instance, in January 2020, DxFLEX, CE-IVD, a 13-colour clinical flow cytometry system was launched by Beckman Coulter Life Sciences in Europe. Similarly, easy cellular analysis by simultaneous evaluation of several parameters allows extensive use of such devices for contract research purposes. The COVID-19 pandemic also spurred innovations in the technique, as evidenced by the launch of new products in this domain. For instance, in July 2021, Metropolis Healthcare Ltd. launched CoviRisk-TBNK, a simple blood test to detect the risk status of a COVID-19 hospitalized patient.

It helps analyze patients' need for ICU facilities or ventilation and aids in the reduction of stress on healthcare resources. The test is a flow cytometry-based lymphocyte subset assay and is IVD-approved. Such innovations are anticipated to fuel industry growth in the near future. Moreover, flow cytometry is a significant tool in listing and characterizing immune cells, and is also helpful in recognizing and validating underlying genetic defects. The technique is also used to observe and monitor the immune response of patients after stem cell transplantation, and hence, organ transplantation plays an important role in boosting industry growth. According to the WHO, around 50,000 stem cell transplantations are performed globally every year, and this number is expected to grow in the near future, broadening the scope of applications for the technique.

On the other hand, instruments are highly expensive, and hence, buyers in several developing countries may not be able to afford technologically advanced flow cytometry equipment. These instruments may cost over USD 100,000 and pose significant budgetary constraints for small- & mid-sized hospitals and clinical laboratories. However, some manufacturers, such as Sony, are trying to launch newer instruments using software to automate a number of processes. Such developments would not only improve the usability of the technique but also help bring down the average instrumentation cost-under USD 100,000-in the near future.

Flow Cytometry Market Report Highlights:

  • The instrument product segment held the largest share in 2023 due to technical advancements, as well as increased prevalence of chronic conditions
  • The cell-based flow cytometry technology dominated the industry in 2023 due to the high demand for early diagnosis and rising awareness about the associated benefits of cell-based assays
  • By application, the clinical segment accounted for the largest revenue share in 2023 owing to increased activities pertaining to infectious diseases, such as influenza, HIV, and COVID-19, among others
  • The academic institutes end-user segment led the market in 2023 owing to increased R&D activities by academic institutes & research centers
  • North America was the leading region in 2023 due to the high implementation of scientifically advanced flow cytometry solutions, high healthcare expenditure, and well-established healthcare infrastructure in the region
  • Asia Pacific is expected to register the fastest CAGR from 2022 to 2030 owing to the extensive growth in the pharmaceutical and biotechnology industries in emerging economies, such as China and India

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Regional Scope
    • 1.1.2 Market Definitions
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Objectives
    • 1.2.1 Objective - 1
    • 1.2.2 Objective - 2
    • 1.2.3 Objective - 3
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 GVR's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
    • 1.4.5 Details Of Primary Research
  • 1.5 Information or Data Analysis
    • 1.5.1 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
      • 1.7.1.1 Approach 1: Commodity Flow Approach
      • 1.7.1.2 Approach 2: Country wise market estimation using bottom-up approach
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Product and Technology Segment Snapshot
  • 2.3 Application and End-use Segment Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Market Variables, Trends, and Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Growing prevalence of chronic and infectious diseases
      • 3.2.1.2 High R&D investments in biotechnology, clinical, and life science research
      • 3.2.1.3 Technological advancements in flow cytometry instruments and reagents
      • 3.2.1.4 Increasing demand for point-of-care diagnostics
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High Cost Of Instruments
    • 3.2.3 Industry Challenges
      • 3.2.3.1 Low Cell Throughput Rate
  • 3.3 Business Environment Analysis
    • 3.3.1 Pestel Analysis
    • 3.3.2 Porter's Five Forces Analysis
  • 3.4 COVID-19 Impact Analysis

Chapter 4 Flow Cytometry Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

  • 4.1 Flow Cytometry Market: Product Movement Analysis
  • 4.2 Flow Cytometry Market Estimates & Forecast by Product (USD Million)
    • 4.2.1 Instruments
      • 4.2.1.1 Cell Analyzers
      • 4.2.1.2 Cell Sorters
    • 4.2.2 Reagents & Consumables
    • 4.2.3 Software
    • 4.2.4 Accessories
    • 4.2.5 Services

Chapter 5 Flow Cytometry Market - Segment Analysis, by Technology, 2018 - 2030 (USD Million)

  • 5.1 Flow Cytometry Market: Technology Movement Analysis
  • 5.2 Flow Cytometry Market Estimates & Forecast by Technology (USD Million)
    • 5.2.1 Cell-Based
    • 5.2.2 Bead-Based

Chapter 6 Flow Cytometry Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)

  • 6.1 Flow Cytometry Market: Application Movement Analysis
  • 6.2 Flow Cytometry Market Estimates & Forecast by Application (USD Million)
    • 6.2.1 Research
      • 6.2.1.1 Pharmaceutical
      • 6.2.1.1.1 Drug Discovery
      • 6.2.1.1.2 Stem Cell
      • 6.2.1.1.3 In Vitro Toxicity
      • 6.2.1.2 Apoptosis
      • 6.2.1.3 Cell Sorting
      • 6.2.1.4 Cell Cycle Analysis
      • 6.2.1.5 Immunology
      • 6.2.1.6 Cell Viability
    • 6.2.2 Industrial
    • 6.2.3 Clinical
      • 6.2.3.1 Cancer
      • 6.2.3.2 Organ Transplantation
      • 6.2.3.3 Immunodeficiency
      • 6.2.3.4 Hematology
      • 6.2.3.5 Autoimmune Disorders

Chapter 7 Flow Cytometry Market - Segment Analysis, by End Use, 2018 - 2030 (USD Million)

  • 7.1 Flow Cytometry Market: End-use Movement Analysis
  • 7.2 Flow Cytometry Market Estimates & Forecast by End Use (USD Million)
    • 7.2.1 Commercial Organizations
      • 7.2.1.1 Biotechnology Companies
      • 7.2.1.2 Pharmaceutical Companies
      • 7.2.1.3 Cros
    • 7.2.2 Hospitals
    • 7.2.3 Academic Institutes
    • 7.2.4 Clinical Testing Labs

Chapter 8 Flow Cytometry Market: Regional Estimates and Trend Analysis, By Product, Technology, Application, and End Use

  • 8.1 Flow Cytometry Market: Regional Outlook
  • 8.2 North America
    • 8.2.1 North America Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 Key Country Dynamics
      • 8.2.2.2 U.S. Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.2.2.3 Competitive/Market Scenario
      • 8.2.2.4 Regulatory Framework
      • 8.2.2.5 Reimbursement Scenario
    • 8.2.3 Canada
      • 8.2.3.1 Key Country Dynamics
      • 8.2.3.2 Canada flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.2.3.3 Competitive/Market Scenario
      • 8.2.3.4 Regulatory Framework
      • 8.2.3.5 Reimbursement Scenario
  • 8.3 Europe
    • 8.3.1 Europe Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2 UK
      • 8.3.2.1 Key Country Dynamics
      • 8.3.2.2 UK Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.2.3 Competitive/Market Scenario
      • 8.3.2.4 Regulatory Framework
      • 8.3.2.5 Reimbursement Scenario
    • 8.3.3 Germany
      • 8.3.3.1 Key Country Dynamics
      • 8.3.3.2 Germany Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.3.3 Competitive/Market Scenario
      • 8.3.3.4 Regulatory Framework
      • 8.3.3.5 Reimbursement Scenario
    • 8.3.4 France
      • 8.3.4.1 Key Country Dynamics
      • 8.3.4.2 France Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.4.3 Competitive Scenario
      • 8.3.4.4 Regulatory Framework
      • 8.3.4.5 Reimbursement Scenario
    • 8.3.5 Italy
      • 8.3.5.1 Key Country Dynamics
      • 8.3.5.2 Italy Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.5.3 Competitive/Market Scenario
      • 8.3.5.4 Regulatory Framework
      • 8.3.5.5 Reimbursement Scenario
    • 8.3.6 Spain
      • 8.3.6.1 Key Country Dynamics
      • 8.3.6.2 Spain Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.6.3 Competitive/Market Scenario
      • 8.3.6.4 Regulatory Framework
      • 8.3.6.5 Reimbursement Scenario
    • 8.3.7 Denmark
      • 8.3.7.1 Key Country Dynamics
      • 8.3.7.2 Denmark Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.7.3 Competitive/Market Scenario
      • 8.3.7.4 Regulatory Framework
      • 8.3.7.5 Reimbursement Scenario
    • 8.3.8 Sweden
      • 8.3.8.1 Key Country Dynamics
      • 8.3.8.2 Sweden Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.8.3 Competitive/Market Scenario
      • 8.3.8.4 Regulatory Framework
    • 8.3.9 Norway
      • 8.3.9.1 Key Country Dynamics
      • 8.3.9.2 Norway Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.3.9.3 Competitive/Market Scenario
      • 8.3.9.4 Regulatory Framework
      • 8.3.9.5 Reimbursement Scenario
    • 8.3.10 Rest Of Europe Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Key Country Dynamics
      • 8.4.2.2 Japan Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.2.3 Competitive/Market Scenario
      • 8.4.2.4 Regulatory Framework
      • 8.4.2.5 Reimbursement Scenario
    • 8.4.3 China
      • 8.4.3.1 Key Country Dynamics
      • 8.4.3.2 China Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.3.3 Competitive/Market Scenario
      • 8.4.3.4 Regulatory Framework
      • 8.4.3.5 Reimbursement Scenario
    • 8.4.4 India
      • 8.4.4.1 Key Country Dynamics
      • 8.4.4.2 India Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.4.3 Competitive/Market Scenario
      • 8.4.4.4 Regulatory Framework
      • 8.4.4.5 Reimbursement Scenario
    • 8.4.5 Australia
      • 8.4.5.1 Key Country Dynamics
      • 8.4.5.2 Australia Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.5.3 Competitive/Market Scenario
      • 8.4.5.4 Regulatory Framework
      • 8.4.5.5 Reimbursement Scenario
    • 8.4.6 Thailand
      • 8.4.6.1 Key Country Dynamics
      • 8.4.6.2 Thailand Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.6.3 Competitive/Market Scenario
      • 8.4.6.4 Regulatory Framework
      • 8.4.6.5 Reimbursement Scenario
    • 8.4.7 South Korea
      • 8.4.7.1 Key Country Dynamics
      • 8.4.7.2 South Korea Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.7.3 Competitive/Market Scenario
      • 8.4.7.4 Regulatory Framework
      • 8.4.7.5 Reimbursement Scenario
    • 8.4.8 Singapore
      • 8.4.8.1 Key Country Dynamics
      • 8.4.8.2 Singapore Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 8.4.8.3 Competitive Scenario
      • 8.4.8.4 Regulatory Framework
      • 8.4.8.5 Reimbursement Scenario
    • 8.4.9 Rest Of Asia Pacific Flow Cytometry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Key Country Dynamics
      • 8.5.2.2 Brazil Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
      • 8.5.2.3 Competitive/Market Scenario
      • 8.5.2.4 Regulatory Framework
      • 8.5.2.5 Reimbursement Scenario
    • 8.5.3 Mexico
      • 8.5.3.1 Key Country Dynamics
      • 8.5.3.2 Mexico Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
      • 8.5.3.3 Competitive/Market Scenario
      • 8.5.3.4 Regulatory Framework
      • 8.5.3.5 Reimbursement Scenario
    • 8.5.4 Argentina
      • 8.5.4.1 Key Country Dynamics
      • 8.5.4.2 Argentina Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
      • 8.5.4.3 Competitive/Market Scenario
      • 8.5.4.4 Regulatory Framework
      • 8.5.4.5 Rest of Latin America Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
  • 8.6 MEA
    • 8.6.1 MEA Flow Cytometry Market Estimates And Forecasts, 2018 - 2030, (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 Key Country Dynamics
      • 8.6.2.2 South Africa Flow Cytometry Market Estimates and Forecasts, 2018 - 2030, (USD Million)
      • 8.6.2.3 Competitive Scenario
      • 8.6.2.4 Regulatory Framework
      • 8.6.2.5 Reimbursement Scenario
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Key Country Dynamics
      • 8.6.3.2 Saudi Arabia Flow Cytometry Market Estimates and Forecasts, 2018 - 2030, (USD Million)
      • 8.6.3.3 Competitive Scenario
      • 8.6.3.4 Regulatory Framework
      • 8.6.3.5 Reimbursement Scenario
    • 8.6.4 UAE
      • 8.6.4.1 Key Country Dynamics
      • 8.6.4.2 UAE Flow Cytometry Market Estimates and Forecasts, 2018 - 2030, (USD Million)
      • 8.6.4.3 Competitive Scenario
      • 8.6.4.4 Regulatory Framework
      • 8.6.4.5 Reimbursement Scenario
    • 8.6.5 Kuwait
      • 8.6.5.1 Key Country Dynamics
      • 8.6.5.2 Kuwait Flow Cytometry Market Estimates and Forecasts, 2018 - 2030, (USD Million)
      • 8.6.5.3 Competitive Scenario
      • 8.6.5.4 Regulatory Framework
      • 8.6.5.5 Reimbursement Scenario
    • 8.6.6 Rest Of Mea Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Company Profiles
    • 9.7.1 DANAHER CORPORATION
      • 9.7.1.1 Company overview
      • 9.7.1.2 Beckman Coulter, Inc.
      • 9.7.1.2.1 Company Overview
      • 9.7.1.3 Cytiva
      • 9.7.1.3.1 Company Overview
      • 9.7.1.4 Financial performance
      • 9.7.1.5 Product benchmarking
      • 9.7.1.6 Strategic initiatives
    • 9.7.2 BECTON, DICKINSON AND COMPANY (BD)
      • 9.7.2.1 Company overview
      • 9.7.2.2 Financial performance
      • 9.7.2.3 Product benchmarking
      • 9.7.2.4 Strategic initiatives
    • 9.7.3 SYSMEX CORPORATION
      • 9.7.3.1 Company overview
      • 9.7.3.2 Financial performance
      • 9.7.3.3 Product benchmarking
      • 9.7.3.4 Strategic initiatives
    • 9.7.4 AGILENT TECHNOLOGIES, INC.
      • 9.7.4.1 Company overview
      • 9.7.4.2 Financial performance
      • 9.7.4.3 Product benchmarking
      • 9.7.4.4 Strategic initiatives
    • 9.7.5 APOGEE FLOW SYSTEMS LTD.
      • 9.7.5.1 Company overview
      • 9.7.5.2 Product benchmarking
      • 9.7.5.3 Strategic initiatives
    • 9.7.6 BIO-RAD LABORATORIES, INC.
      • 9.7.6.1 Company overview
      • 9.7.6.2 Financial performance
      • 9.7.6.3 Product benchmarking
      • 9.7.6.4 Strategic initiatives
    • 9.7.7 THERMO FISHER SCIENTIFIC, INC.
      • 9.7.7.1 Company overview
      • 9.7.7.2 Financial performance
      • 9.7.7.3 Product benchmarking
      • 9.7.7.4 Strategic initiatives
    • 9.7.8 STRATEDIGM, INC.
      • 9.7.8.1 Company overview
      • 9.7.8.2 Product benchmarking
  • 9.2 Company Categorization
  • 9.3 Flow cytometry Market Share Analysis, 2023
  • 9.4 Strategy Mapping
    • 9.4.1 Mergers & Acquisitions
    • 9.4.2 Partnerships And Collaborations
    • 9.4.3 New Product Launch
    • 9.4.4 Others

Chapter 10 Conclusion

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Regulatory status and recommended validation strategy for flow cytometry assays
  • Table 3 CPT codes for flow cytometry reimbursement
  • Table 4 Global flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 5 Global flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 6 Global flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 7 Global flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 8 Global flow cytometry market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 11 North America flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 12 North America flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 13 North America flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. Flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 15 U.S. Flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. Flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 17 U.S. Flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 18 Canada flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 19 Canada flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 20 Canada flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 21 Canada flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 22 Europe flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 23 Europe flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 24 Europe flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 25 Europe flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 26 Europe flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 27 Germany flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 28 Germany flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 29 Germany flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 30 Germany flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 31 U.K. flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 32 U.K. flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 33 U.K. flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 34 U.K. flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 35 France flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 36 France flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 37 France flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 38 France flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 39 Italy flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 40 Italy flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 41 Italy flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 42 Italy flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 43 Spain flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 44 Spain flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Spain flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 46 Spain flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 47 Denmark flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 48 Denmark flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Denmark flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 50 Denmark flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 51 Sweden flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 52 Sweden flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 53 Sweden flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 54 Sweden flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 55 Norway flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 56 Norway flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Norway flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 58 Norway flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 59 Asia pacific flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 60 Asia pacific flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 61 Asia pacific flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Asia pacific flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 63 Asia pacific flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 64 China flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 65 China flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 66 China flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 67 China flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 68 India flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 69 India flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 70 India flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 71 India flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 72 Japan flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 73 Japan flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Japan flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 75 Japan flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 76 South Korea flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 77 South Korea flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 78 South Korea flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 79 South Korea flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 80 Australia flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 81 Australia flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 82 Australia flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 83 Australia flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 84 Thailand flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 85 Thailand flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 86 Thailand flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 87 Thailand flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 88 Singapore flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 89 Singapore flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Singapore flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 91 Singapore flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 92 Latin America flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 93 Latin America flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 94 Latin America flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 95 Latin America flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 96 Latin America flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 97 Brazil flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 98 Brazil flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 99 Brazil flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 100 Brazil flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 101 Mexico flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 102 Mexico flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 103 Mexico flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 104 Mexico flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 105 Argentina flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 106 Argentina flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 107 Argentina flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 108 Argentina flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 109 Middle east & Africa flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 110 Middle east & Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 111 Middle east & Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 112 Middle east & Africa flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 113 Middle east & Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 114 South Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 115 South Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 116 South Africa flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 117 South Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 118 Saudi Arabia flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 119 Saudi Arabia flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 120 Saudi Arabia flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 121 Saudi Arabia flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 122 UAE flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 123 UAE flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 124 UAE flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 125 UAE flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 126 Kuwait flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 127 Kuwait flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 128 Kuwait flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 129 Kuwait flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 130 Company Market Share Analysis, 2023

List of Figures

  • Fig. 1 Flow cytometry market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product and technology segment snapshot
  • Fig. 10 Application and end-use segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Life science tools market value, 2023 (USD Billion)
  • Fig. 13 Market dynamics
  • Fig. 14 PESTEL analysis
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Flow cytometry market: Product outlook and key takeaways
  • Fig. 17 Flow cytometry market: Product movement analysis
  • Fig. 18 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Cell analyzers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Cell sorters market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Reagents & consumables market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 22 Software market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 23 Accessories market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 24 Services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 25 Flow cytometry market: Technology outlook and key takeaways
  • Fig. 26 Flow cytometry market: Technology movement analysis
  • Fig. 27 Cell-based market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Bead-based market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Flow cytometry market: Application outlook and key takeaways
  • Fig. 30 Flow cytometry market: Application movement analysis
  • Fig. 31 Research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Pharmaceutical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Drug discovery market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Stem cell market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 In vitro toxicity market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Apoptosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Cell sorting market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Cell cycle analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Immunology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Cell viability market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Industrial market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Organ transplantation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Immunodeficiency market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Autoimmune disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Flow cytometry market: End-use outlook and key takeaways
  • Fig. 49 Flow cytometry market: End-use movement analysis
  • Fig. 50 Commercial organizations market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Pharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 CROs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Academic institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Clinical testing labs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Flow cytometry market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 58 Regional marketplace: Key takeaways
  • Fig. 59 Regional marketplace: Key takeaways
  • Fig. 60 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 U.S. flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Canada flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Europe flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 UK flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Germany flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 France flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Italy flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Spain flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Denmark flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Sweden flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Norway flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Rest of Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Asia Pacific flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Japan flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 China flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 India flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Australia flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Thailand flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 South Korea flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Singapore flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Rest of Asia Pacific flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Latin America flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Brazil flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Mexico flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 Key country dynamics
  • Fig. 105 Argentina flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 106 Rest of Latin America flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 MEA flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 South Africa flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 110 Key country dynamics
  • Fig. 111 Saudi Arabia flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 112 Key country dynamics
  • Fig. 113 UAE flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 114 Key country dynamics
  • Fig. 115 Kuwait flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 116 Rest of MEA flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 117 Key company categorization
  • Fig. 118 Flow cytometry market share analysis, 2023
  • Fig. 119 Strategy mapping